Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

Leuk Lymphoma. 2019 Mar;60(3):856-859. doi: 10.1080/10428194.2018.1509322. Epub 2018 Sep 20.

¹ a Hospital Puerta de Hierro Majadahonda , Madrid , Spain.
² b Department of Medical Oncology , Hospital Puerta de Hierro , Majadahonda , Spain.
³ c Department of Medical Oncology , Hospital La Fe , Valencia , Spain.
⁴ d Hospital Clinico de Malaga , Malaga , Spain.
⁵ e Department of Medical Oncology , Hospital Universitario de Canaras , Tenerife , Spain.
⁶ f Department of Medical Oncology , Hospital de Pontevedra , Pontevedra , Spain.
⁷ g Department of Medical Oncology , Hospital Universitario Virgen Macarena , Sevilla , Spain.
⁸ h Department of Medical Oncology , Hospital Universitario de Reus , Reus , Spain.
⁹ i Department of Medical Oncology , Hospital Virgen de las Nieves , Granada , Spain.
¹⁰ j Department of Medical Oncology , Hospital Universitario Virgen de la Salud , Toledo , Spain.
¹¹ k Department of Biostatistic , Hospital Universitario Puerta del Hierro Majadahonda , Majadahonda , Spain.
¹² l Department of Medical Oncology , Hospital Costa del Sol , Marbella , Spain.

No abstract available

Publication types